Pharmaceutical and Biomedical Project Management in a Changing Global Environment: 8 (Wiley Series on Technologies for the Pharmaceutical Industry) - Tapa dura

"The book is an excellent primer and "hands on" reference text focused on the unique aspects of managing projects in the life sciences. Practical tips and tools are offered for wide ranging topics relevant to those working in both large pharma and small biotech, in both US focused and global settings." ?Barbara Rosengren, Vice President, Strategic Product Development, Momenta Pharmaceuticals Inc "I love this book and absolutely want to keep a copy on my shelf. It feels like a PMO in a box ? I will be able to open it up and get my questions answered, confirm what I am thinking, and look for other ways to approach and solve problems. The writing across the board is consistently strong, the organization makes sense and it reads well ? almost like a fast-paced fiction novel!" ?Kathleen Monroe, Vice President, Imaging Services, Synarc "I found the book to be practical and timely in providing up-to-date information for project managers in this evolving area of practice. The book provides a good view of the broad landscape of current project management challenges in a quickly evolving industry. It is an excellent grounding for project managers in the biomedical industry and a highly recommended text for those who want hands-on advice from professionals that are actively engaged in the field. This book is valuable for project management practitioners as well as for senior managers who seek a better understanding of the complexities of project management in the current biomedical environment." ?Elaine Alexander, Sr Project Manager, Global Medical Company

Pharmaceutical and Biomedical Portfolio Management in a Changing Global Environment explores some of the critical forces at work today in the complex endeavour of pharmaceutical and medical product development. Written by experienced professionals, and including real-world approaches and best practice examples, this new title addresses three key areas - small molecules, large molecules, and medical devices - and provides hard-to-find, consolidated information relevant to and needed by pharmaceutical, biotech, and medical device company managers.